BELLETORUS CORPORATION - ARPA-H O1 SBIR PHASE II - NOVEL TELEHEALTH INSTRUMENTS FOR ASSESSING PEDIATRIC WELL-BEING. PROJECT TITLE: DIGITAL ASSESSMENT OF CHILDREN'S CONDITIONS USING ARTIFICIAL INTELLIGENCE ("DACCS AI")
Key Details
Description
ARPA-H O1 SBIR PHASE II - NOVEL TELEHEALTH INSTRUMENTS FOR ASSESSING PEDIATRIC WELL-BEING. PROJECT TITLE: DIGITAL ASSESSMENT OF CHILDREN'S CONDITIONS USING ARTIFICIAL INTELLIGENCE ("DACCS AI")
Context & Analysis
On Feb 4, 2026, Department of Health and Human Services obligated $3,480,960 to BELLETORUS CORPORATION for arpa-h o1 sbir phase ii - novel telehealth instruments for assessing pediatric well-being. project title: digital assessment of children's conditions using artificial intelligence ("daccs ai"). The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition after exclusion of sources with 7 offers received. The procurement used a SMALL BUSINESS SET ASIDE - TOTAL set-aside. Performance is located in CAMBRIDGE, MA. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.
Contractor Information
Similar Awards
NCI OPERATIONAL TASK ORDER, FY26-FY27
LEIDOS BIOMEDICAL RESEARCH INC
$327.1M
MD NET
LEIDOS BIOMEDICAL RESEARCH INC
$163.5M
ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)
LEIDOS BIOMEDICAL RESEARCH INC
$141.7M
AWARD OF THE BASE TO ST. JUDE FOR CEIRR CONTRACT 75N93021C00016. THIS CONTRACT WILL SUPPORT NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR).
ST JUDE CHILDREN'S RESEARCH HOSPITAL INC
$103.3M
DOMESTIC INDUSTRIAL BASE EXPANSION OF KEY CHEMICALS FOR ACRYLONITRILE BUTADIENE RUBBER (NBR)
ASCEND PERFORMANCE MATERIALS TEXAS INC
$87.7M
Stay Updated
Get notified about new opportunities matching your interests.